Aptamers as targeted therapeutics: current potential and challenges
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aptamers as targeted therapeutics: current potential and challenges
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 16, Issue 3, Pages 181-202
Publisher
Springer Nature
Online
2016-11-03
DOI
10.1038/nrd.2016.199
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Embracing proteins: structural themes in aptamer–protein complexes
- (2016) Amy D Gelinas et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
- (2016) Nancy J. Ganson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies
- (2016) Kyun Heo et al. JOURNAL OF CONTROLLED RELEASE
- An anticoagulant too good to be true for revascularisation
- (2016) Freek W A Verheugt LANCET
- Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
- (2016) A Michael Lincoff et al. LANCET
- Smooth Muscle Cell–targeted RNA Aptamer Inhibits Neointimal Formation
- (2016) William H Thiel et al. MOLECULAR THERAPY
- Ten years of anti-vascular endothelial growth factor therapy
- (2016) Napoleone Ferrara et al. NATURE REVIEWS DRUG DISCOVERY
- Aptamers as radiopharmaceuticals for nuclear imaging and therapy
- (2016) Marlies Gijs et al. NUCLEAR MEDICINE AND BIOLOGY
- Fit for the Eye: Aptamers in Ocular Disorders
- (2016) Daniel W. Drolet et al. Nucleic Acid Therapeutics
- Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant
- (2016) Erin E. Soule et al. Nucleic Acid Therapeutics
- 2′Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors
- (2016) Youngju Lee et al. Nucleic Acid Therapeutics
- Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology
- (2015) Dan Shu et al. ACS Nano
- Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation
- (2015) Yeh-Hsing Lao et al. ACS Nano
- The roles of nucleolin subcellular localization in cancer
- (2015) Caroline Madeleine Berger et al. BIOCHIMIE
- 2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia
- (2015) Mario Martinez Soldevilla et al. BIOMATERIALS
- Current approaches in SELEX: An update to aptamer selection technology
- (2015) Mariia Darmostuk et al. BIOTECHNOLOGY ADVANCES
- Hi-Fi SELEX: A high-fidelity digital-PCR based therapeutic aptamer discovery platform
- (2015) Eric Ouellet et al. BIOTECHNOLOGY AND BIOENGINEERING
- Cancer immunotherapy via nucleic acid aptamers
- (2015) Mostafa Khedri et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates
- (2015) Silvia Catuogno et al. JOURNAL OF CONTROLLED RELEASE
- Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy
- (2015) Chao Liang et al. NATURE MEDICINE
- Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment
- (2015) Agata Levay et al. NUCLEIC ACIDS RESEARCH
- Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation
- (2015) Na-Oh Yunn et al. NUCLEIC ACIDS RESEARCH
- Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discovery
- (2015) Jan Hoinka et al. NUCLEIC ACIDS RESEARCH
- The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation
- (2015) Liang Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Smart functional nucleic acid chimeras: Enabling tissue specific RNA targeting therapy
- (2015) Lukas J Aaldering et al. RNA Biology
- Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2
- (2015) Dominik Oberthür et al. Nature Communications
- DNA Aptamer Assembly as a Vascular Endothelial Growth Factor Receptor Agonist
- (2015) Vidhya Ramaswamy et al. Nucleic Acid Therapeutics
- Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein
- (2015) Chang Ho Lee et al. Molecular Therapy-Nucleic Acids
- Identification and Characterization of an Agonistic Aptamer Against the T Cell Costimulatory Receptor, OX40
- (2015) Elizabeth D. Pratico et al. Nucleic Acid Therapeutics
- Emulsion PCR Significantly Improves Nonequilibrium Capillary Electrophoresis of Equilibrium Mixtures-Based Aptamer Selection: Allowing for Efficient and Rapid Selection of Aptamer to Unmodified ABH2 Protein
- (2014) Roman Yufa et al. ANALYTICAL CHEMISTRY
- NOX-A12: mobilizing CLL away from home
- (2014) R. Marasca et al. BLOOD
- Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study
- (2014) David S Boyer et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Probing the Coagulation Pathway with Aptamers Identifies Combinations that Synergistically Inhibit Blood Clot Formation
- (2014) Kristin M. Bompiani et al. CHEMISTRY & BIOLOGY
- Factor IXa as a target for anticoagulation in thrombotic disorders and conditions
- (2014) Dia A. Smiley et al. DRUG DISCOVERY TODAY
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Radiolabeling Strategies for Tumor-Targeting Proteinaceous Drugs
- (2014) Grant Sugiura et al. MOLECULES
- Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study
- (2014) Thomas J. Povsic et al. EuroIntervention
- New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization
- (2014) Abdullah Ozer et al. Molecular Therapy-Nucleic Acids
- Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
- (2014) Jiehua Zhou et al. Molecular Therapy-Nucleic Acids
- Stable RNA nanoparticles as potential new generation drugs for cancer therapy
- (2013) Yi Shu et al. ADVANCED DRUG DELIVERY REVIEWS
- The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys
- (2013) F. Schwoebel et al. BLOOD
- The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
- (2013) J. Hoellenriegel et al. BLOOD
- Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors
- (2013) E. Gilboa et al. CLINICAL CANCER RESEARCH
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
- (2013) K Ghasemi Falavarjani et al. EYE
- Immunogenicity of therapeutic proteins: Influence of aggregation
- (2013) Kirsty D. Ratanji et al. Journal of Immunotoxicology
- Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
- (2013) Shivi Agrawal et al. MEDIATORS OF INFLAMMATION
- Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats
- (2013) Shie-Chau Liu et al. NEURO-ONCOLOGY
- Dimeric DNA Aptamer Complexes for High-capacity–targeted Drug Delivery Using pH-sensitive Covalent Linkages
- (2013) Olcay Boyacioglu et al. Molecular Therapy-Nucleic Acids
- CD28 Aptamers as Powerful Immune Response Modulators
- (2013) Fernando Pastor et al. Molecular Therapy-Nucleic Acids
- In vivo SELEX for Identification of Brain-penetrating Aptamers
- (2013) Congsheng Cheng et al. Molecular Therapy-Nucleic Acids
- Aptamer selection by high-throughput sequencing and informatic analysis
- (2012) Shawn Hoon et al. BIOTECHNIQUES
- A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial
- (2012) Thomas J. Povsic et al. EUROPEAN HEART JOURNAL
- Therapeutic RNA aptamers in clinical trials
- (2012) Padma Sundaram et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Functional In Vivo Delivery of Multiplexed Anti-HIV-1 siRNAs via a Chemically Synthesized Aptamer With a Sticky Bridge
- (2012) Jiehua Zhou et al. MOLECULAR THERAPY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer
- (2012) Domenica Musumeci et al. PHARMACOLOGY & THERAPEUTICS
- Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection
- (2012) William H. Thiel et al. PLoS One
- Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor
- (2011) E. K. Waters et al. BLOOD
- Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy
- (2011) T. J. Povsic et al. EUROPEAN HEART JOURNAL
- Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts
- (2011) Xiaohua Ni et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
- (2011) Fernando Pastor et al. MOLECULAR THERAPY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
- (2011) Larry Gold et al. PLoS One
- Emulsion PCR: A High Efficient Way of PCR Amplification of Random DNA Libraries in Aptamer Selection
- (2011) Keke Shao et al. PLoS One
- SUSTAINED ELEVATED INTRAOCULAR PRESSURES AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, RANIBIZUMAB, AND PEGAPTANIB
- (2011) Daniel Y Choi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Nucleotide Bias Observed with a Short SELEX RNA Aptamer Library
- (2011) William H. Thiel et al. Nucleic Acid Therapeutics
- A streamlined protocol for emulsion polymerase chain reaction and subsequent purification
- (2010) Tatjana Schütze et al. ANALYTICAL BIOCHEMISTRY
- Current Status of Vascular Endothelial Growth Factor Inhibition in Age-Related Macular Degeneration
- (2010) Shaker A. Mousa et al. BIODRUGS
- A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism
- (2010) E. M. Reyes-Reyes et al. CANCER RESEARCH
- Engineering Dendritic Aptamer Assemblies as Superior Inhibitors of Protein Function
- (2010) Youngmi Kim et al. Chemistry-An Asian Journal
- First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention
- (2010) Mauricio G. Cohen et al. CIRCULATION
- Lipophilicity in drug discovery
- (2010) Michael J Waring Expert Opinion on Drug Discovery
- Expanding the Chemistry of DNA for in Vitro Selection
- (2010) Jonathan D. Vaught et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A dual-targeting PDGFRβ/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo
- (2010) Robert Mabry et al. mAbs
- Molecular Evolution of Functional Nucleic Acids with Chemical Modifications
- (2010) Masayasu Kuwahara et al. MOLECULES
- Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
- (2010) Fernando Pastor et al. NATURE
- The emerging field of RNA nanotechnology
- (2010) Peixuan Guo Nature Nanotechnology
- Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures
- (2010) Günter Mayer et al. Nature Protocols
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- Pitfalls of Cell-Systematic Evolution of Ligands by Exponential Enrichment (SELEX): Existing Dead Cells During In Vitro Selection Anticipate the Enrichment of Specific Aptamers
- (2010) Meltem Avci-Adali et al. OLIGONUCLEOTIDES
- Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing
- (2010) M. Cho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA-Based Gene Therapy for HIV with Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
- (2010) D. L. DiGiusto et al. Science Translational Medicine
- A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease
- (2010) Petra Paulinska et al. THROMBOSIS AND HAEMOSTASIS
- Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura
- (2010) Bernd Jilma et al. THROMBOSIS AND HAEMOSTASIS
- Targeting cancer cells with nucleic acid aptamers
- (2010) Laura Cerchia et al. TRENDS IN BIOTECHNOLOGY
- A dual function TAR Decoy serves as an anti-HIV siRNA delivery vehicle
- (2010) Hoshang J Unwalla et al. Virology Journal
- The Chemical Biology of Aptamers
- (2009) Günter Mayer ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Integrated microfluidic system for rapid screening of CRP aptamers utilizing systematic evolution of ligands by exponential enrichment (SELEX)
- (2009) Chao-June Huang et al. BIOSENSORS & BIOELECTRONICS
- Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes
- (2009) S. G. Sayyed et al. DIABETOLOGIA
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- VEGF inhibitors for the treatment of neovascular age-related macular degeneration
- (2009) Mark Rami Barakat et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The molecular mechanisms of immunomodulation and tolerance induction to factor VIII
- (2009) B. WATERS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779
- (2009) J. L. DIENER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A Hybrid DNA Aptamer-Dendrimer Nanomaterial for Targeted Cell Labeling
- (2009) Jing Zhou et al. MACROMOLECULAR BIOSCIENCE
- Locked nucleic acid nucleoside triphosphates and polymerases: on the way towards evolution of LNA aptamers
- (2009) Rakesh N. Veedu et al. Molecular BioSystems
- Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
- (2009) S. Soundararajan et al. MOLECULAR PHARMACOLOGY
- Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
- (2009) Justin P Dassie et al. NATURE BIOTECHNOLOGY
- In vivo selection of tumor-targeting RNA motifs
- (2009) Jing Mi et al. Nature Chemical Biology
- Selection of DNA aptamers using atomic force microscopy
- (2009) Yusuke Miyachi et al. NUCLEIC ACIDS RESEARCH
- Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells
- (2009) Jiehua Zhou et al. NUCLEIC ACIDS RESEARCH
- The Complement Component 5 Gene and Age-Related Macular Degeneration
- (2009) Dominique C. Baas et al. OPHTHALMOLOGY
- Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin
- (2009) S. M. Nimjee et al. RNA
- Late Onset of Ccl2 Blockade with the Spiegelmer mNOX-E36–3′PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db/db Mice
- (2008) Volha Ninichuk et al. AMERICAN JOURNAL OF PATHOLOGY
- Applications of aptamers in cancer cell biology
- (2008) Joseph A. Phillips et al. ANALYTICA CHIMICA ACTA
- Enrichment of Cell‐Targeting and Population‐Specific Aptamers by Fluorescence‐Activated Cell Sorting
- (2008) Marie‐Sophie L. Raddatz et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells
- (2008) S. Soundararajan et al. CANCER RESEARCH
- Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating Aptamer
- (2008) Claudia M. Dollins et al. CHEMISTRY & BIOLOGY
- Cell-Specific Induction of Apoptosis by Rationally Designed Bivalent Aptamer-siRNA Transcripts Silencing Eukaryotic Elongation Factor 2
- (2008) Ulrich Wullner et al. CURRENT CANCER DRUG TARGETS
- SELEX with modified nucleotides
- (2008) Anthony D Keefe et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- CELL-SELEX: Novel Perspectives of Aptamer-Based Therapeutics
- (2008) Ke-Tai Guo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
- (2008) James O. McNamara et al. JOURNAL OF CLINICAL INVESTIGATION
- Novel Dual Inhibitory Function Aptamer–siRNA Delivery System for HIV-1 Therapy
- (2008) Jiehua Zhou et al. MOLECULAR THERAPY
- Cell-Specific Internalization Study of an Aptamer from Whole Cell Selection
- (2007) Zeyu Xiao et al. CHEMISTRY-A EUROPEAN JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started